M E Rosenthale - JoVE Visualize

Showing results (11-20 of 29) with videos related to

Pageof 3

Sort By:

Agents and Actions|February 1, 1987

The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesiaB Dubinsky, S Gebre-Mariam, R J Capetola, et al.

The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987

Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogsL B Katz, D A Shriver, A J Tobia, et al.

Clinics in Rheumatic Diseases|August 1, 1984

Suprofen: the pharmacology and clinical efficacy of a new non-narcotic peripheral analgesicE L Tolman, M E Rosenthale, R J Capetola, et al.

Contraception|July 1, 1984

Antifertility activity and general pharmacological properties of ORF 13811: a synthetic analog of zoapatanolD W Hahn, A J Tobia, M E Rosenthale, et al.

Agents and Actions|July 1, 1981

SRS-A mediated bronchospasm by pharmacologic modification of lung anaphylaxis in vivoD M Ritchie, J N Sierchio, R J Capetola, et al.

Life Sciences|September 28, 1987

Antigastrolesive, gastric antisecretory, diarrheagenic and mucus-stimulating effects in rats following topically applied rioprostil, a synthetic prostaglandin E1 analogL B Katz, T Genna, C K Scott, et al.

International Archives of Allergy and Applied Immunology|January 1, 1984

The comparative bronchodilator properties of alkyl quaternary salts of promethazineA J Lewis, A Dervinis, M E Rosenthale, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 1, 1976

Immunopharmacologic properties of WY-16,922, a new orally effective antiallergic agentM E Rosenthale, A J Begany, A Dervinis, et al.

The Journal of Pharmacology and Experimental Therapeutics|June 1, 1976

Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agentM E Rosenthale, A J Begany, A Dervinis, et al.

Journal of Immunopharmacology|January 1, 1980

Immunopharmacologic properties of 1,6-bis[2-(diethylamino)ethoxy]xanthen-9-one dihydrochloride (Wy-15297)M E Rosenthale, A A Santilli, A C Scotese, et al.

Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:

Pageof 3

Agents and Actions|February 1, 1987

The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesiaB Dubinsky, S Gebre-Mariam, R J Capetola, et al.

The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987

Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogsL B Katz, D A Shriver, A J Tobia, et al.

Clinics in Rheumatic Diseases|August 1, 1984

Suprofen: the pharmacology and clinical efficacy of a new non-narcotic peripheral analgesicE L Tolman, M E Rosenthale, R J Capetola, et al.

Contraception|July 1, 1984

Antifertility activity and general pharmacological properties of ORF 13811: a synthetic analog of zoapatanolD W Hahn, A J Tobia, M E Rosenthale, et al.

Agents and Actions|July 1, 1981

SRS-A mediated bronchospasm by pharmacologic modification of lung anaphylaxis in vivoD M Ritchie, J N Sierchio, R J Capetola, et al.

Life Sciences|September 28, 1987

Antigastrolesive, gastric antisecretory, diarrheagenic and mucus-stimulating effects in rats following topically applied rioprostil, a synthetic prostaglandin E1 analogL B Katz, T Genna, C K Scott, et al.

International Archives of Allergy and Applied Immunology|January 1, 1984

The comparative bronchodilator properties of alkyl quaternary salts of promethazineA J Lewis, A Dervinis, M E Rosenthale, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 1, 1976

Immunopharmacologic properties of WY-16,922, a new orally effective antiallergic agentM E Rosenthale, A J Begany, A Dervinis, et al.

The Journal of Pharmacology and Experimental Therapeutics|June 1, 1976

Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agentM E Rosenthale, A J Begany, A Dervinis, et al.

Journal of Immunopharmacology|January 1, 1980

Immunopharmacologic properties of 1,6-bis[2-(diethylamino)ethoxy]xanthen-9-one dihydrochloride (Wy-15297)M E Rosenthale, A A Santilli, A C Scotese, et al.

Pageof 3